Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001346824-26-000002
Filing Date
2026-01-07
Accepted
2026-01-07 16:53:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12365
2 JOINT FILING AGREEMENT ex-99-01072026_090121.htm EX-99.1 4563
  Complete submission text file 0001346824-26-000002.txt   18861
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Subject) CIK: 0001816736 (see all company filings)

EIN.: 851612845 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91633 | Film No.: 26516340
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)